Zamengo L, Frison G, Bettin C, Sciarrone R (2014) Understanding the risks associated with the use of new psychoactive substances (NPS): High variability of active ingredients concentration, mislabelled preparations, multiple psychoactive substances in single products. Toxicol Lett 229:220–228. https://doi.org/10.1016/j.toxlet.2014.06.012

Article  CAS  PubMed  Google Scholar 

United Nations, Office on Drugs and Crime (2022) Current NPS threats, vol 5. United Nations, Office on Drugs and Crime, Vienna, pp 1–6

Google Scholar 

Alves VL, Gonçalves JL, Aguiar J, Teixeira HM, Câmara JS (2020) The synthetic cannabinoids phenomenon: from structure to toxicological properties A review. Crit Rev Toxicol 50(5):359–382. https://doi.org/10.1080/10408444.2020.1762539

Article  CAS  PubMed  Google Scholar 

Rodrigues TB, Souza MP et al (2022) Synthetic cannabinoid receptor agonists profile in infused papers seized in Brazilian prisons. Forensic Toxicol 40(1):119–124. https://doi.org/10.1007/s11419-021-00586-7

Article  CAS  PubMed  Google Scholar 

Brunt TM, Bossong MG (2022) The neuropharmacology of cannabinoid receptor ligands in central signaling pathways. Eur J Neurosci 55(4):909–921. https://doi.org/10.1111/ejn.14982

Article  CAS  PubMed  Google Scholar 

De Fonseca FR, Gorriti MA, Fernández-Ruiz JJ, Palomo T, Ramos JA (1994) Downregulation of rat brain cannabinoid binding sites after chronic Δ9-tetrahydrocannabinol treatment. Pharmacol Biochem Behav 47(1):33–40. https://doi.org/10.1016/0091-3057(94)90108-2

Article  Google Scholar 

Compton DR, Johnson MR, Melvin LS, Martin BR (1992) Pharmacological profile of a series of bicyclic cannabinoid analogs: Classification as cannabimimetic agents. J Pharmacol Exp Ther 260(1):201–209

CAS  PubMed  Google Scholar 

Langford AM, Bolton JR (2018) Synthetic cannabinoids: Variety is definitely not the spice of life. J Forensic Leg Med 59:36–38. https://doi.org/10.1016/j.jflm.2018.07.012

Article  PubMed  Google Scholar 

King LA (2013) Chapter 1: Legal classification of novel psychoactive substances: an international comparison. In: Dargan PI, Wood DM (eds) Novel psychoactive substances: classification, pharmacology and toxicology. Elsevier, Amsterdam, pp 3–27. https://doi.org/10.1016/B978-0-12-415816-0.00001-8

Chapter  Google Scholar 

Debruyne D, Le Boisselier R (2015) Emerging drugs of abuse: current perspectives on synthetic cannabinoids. Subst Abuse Rehabil 6:113–119. https://doi.org/10.2147/sar.s73586

Article  PubMed  PubMed Central  Google Scholar 

Carlier J, Wohlfarth A, Salmeron BD, Scheidweiler KB, Huestis MA, Baumann MH (2018) Pharmacodynamic effects, pharmacokinetics, and metabolism of the synthetic cannabinoid AM-2201 in male rats. J Pharmacol Exp Ther 367(3):543–550. https://doi.org/10.1124/jpet.118.250530

Article  CAS  PubMed  PubMed Central  Google Scholar 

Funada M, Takebayashi-Ohsawa M (2018) Synthetic cannabinoid AM2201 induces seizures: involvement of cannabinoid CB1 receptors and glutamatergic transmission. Toxicol Appl Pharmacol 338:1–8. https://doi.org/10.1016/j.taap.2017.10.007

Article  CAS  PubMed  Google Scholar 

T’Sarumi O, Nettey V (2019) Cognitive impairment due to synthetic cannabinoids (K2) use and psychosis. Am J Addict 28(3):167–219

Google Scholar 

Dowling G, Regan L (2011) A method for CP 47, 497 a synthetic non-traditional cannabinoid in human urine using liquid chromatography tandem mass spectrometry. J Chromatogr B 879(3–4):253–259. https://doi.org/10.1016/j.jchromb.2010.12.008

Article  CAS  Google Scholar 

Cooper ZD (2016) Adverse effects of synthetic cannabinoids: management of acute toxicity and withdrawal. Curr Psychiatry Rep 18(5):52. https://doi.org/10.1007/s11920-016-0694-1

Article  PubMed  PubMed Central  Google Scholar 

Lapoint J, James LP, Moran CL, Nelson LS, Hoffman RS, Moran JH (2011) Severe toxicity following synthetic cannabinoid ingestion. Clin Toxicol 49(8):760–764. https://doi.org/10.3109/15563650.2011.609822

Article  CAS  Google Scholar 

Nakajima J, Takahashi M, Nonaka R et al (2011) Identification and quantitation of a benzoylindole (2-methoxyphenyl)(1-pentyl-1H-indol-3-yl)methanone and a naphthoylindole 1-(5-fluoropentyl-1H-indol-3-yl)-(naphthalene-1-yl)methanone (AM-2201) found in illegal products obtained via the Internet and their cannabimimetic effects evaluated by in vitro [35S]GTPγS binding assays. Forensic Toxicol 29:95–110. https://doi.org/10.1007/s11419-011-0114-5

Article  CAS  Google Scholar 

Cohen K, Weinstein A (2018) The effects of cannabinoids on executive functions: evidence from cannabis and synthetic cannabinoids a systematic review. Brain Sci 8(3):40. https://doi.org/10.3390/brainsci8030040

Article  CAS  PubMed  PubMed Central  Google Scholar 

Al-Matrouk A, Alqallaf M, AlShemmeri A, BoJbarah H (2019) Identification of synthetic cannabinoids that were seized, consumed, or associated with deaths in Kuwait in 2018 using GC–MS and LC–MS-MS analysis. Forensic Sci Int 303:109960. https://doi.org/10.1016/j.forsciint.2019.109960

Article  CAS  PubMed  Google Scholar 

Somerville RF, Hassan VR, Kolbe E et al (2019) The identification and quantification of synthetic cannabinoids seized in New Zealand in 2017. Forensic Sci Int 300:19–27. https://doi.org/10.1016/j.forsciint.2019.04.014

Article  CAS  PubMed  Google Scholar 

United Nations, Office on Drugs and Crime (2009) Guidance for the validation of analytical methodology and calibration of equipment used for testing of illicit drugs in seized materials and biological specimens. United Nations, Office on Drugs and Crime, Vienna, pp 2–76

Google Scholar 

Duffau BE, Alcamán K (2019) Analysis of three main cannabinoids in seized marijuana by densitometric high-performance thin-layer chromatography. J Planar Chromatogr-Mod TLC 32:343–346. https://doi.org/10.1556/1006.2019.32.4.11

Article  CAS  Google Scholar 

Aranda M, Morlock G (2007) Simultaneous determination of caffeine, ergotamine, and metamizol in solid pharmaceutical formulation by HPTLC-UV-FLD with mass confirmation by online HPTLC-ESI-MS. J Chromatogr Sci 45:251–255

Article  CAS  PubMed  Google Scholar 

United Nations, Office on Drugs and Crime (2011) Synthetic cannabinoids in herbal products. Drugs. Vienna, 1–24.

Uchiyama N, Kikura-Hanajiri R, Ogata J, Goda Y (2010) Chemical analysis of synthetic cannabinoids as designer drugs in herbal products. Forensic Sci Int 198(1–3):31–38. https://doi.org/10.1016/j.forsciint.2010.01.004

Article  CAS  PubMed  Google Scholar